TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)
TWD 7.94
(-0.63%)
TWD 7.94
(-0.63%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -6.61 Million TWD | 95.41% |
| 2022 | -81.7 Million TWD | -693.14% |
| 2021 | -10.3 Million TWD | 75.72% |
| 2020 | -42.43 Million TWD | -534.45% |
| 2019 | -6.68 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -6.74 Million TWD | 0.0% |
| 2024 Q1 | -6.74 Million TWD | 28.64% |
| 2023 Q1 | 6.14 Million TWD | 114.53% |
| 2023 Q3 | -9.45 Million TWD | -253.77% |
| 2023 Q4 | -9.45 Million TWD | 0.0% |
| 2023 FY | -3.74 Million TWD | 95.41% |
| 2023 Q2 | 6.14 Million TWD | 0.0% |
| 2022 Q3 | -42.3 Million TWD | 0.0% |
| 2022 FY | -81.7 Million TWD | -693.14% |
| 2022 Q4 | -42.3 Million TWD | 0.0% |
| 2021 FY | -10.3 Million TWD | 75.72% |
| 2020 FY | -42.43 Million TWD | -534.45% |
| 2019 FY | -6.68 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 102.345% |
| Level Biotechnology Inc. | 67.55 Million TWD | 109.785% |
| Sagittarius Life Science Corp | -64.37 Million TWD | 89.732% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | 92.218% |
| TaiMed Biologics Inc. | -166.23 Million TWD | 96.024% |
| GlycoNex Incorporation | -259.86 Million TWD | 97.456% |
| VBI | -16.13 Million TWD | 59.026% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | 97.117% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | -193.387% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | 92.223% |
| Visgeneer Inc. | -21.15 Million TWD | 68.76% |
| Mycenax Biotech Inc. | -602.1 Million TWD | 98.902% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 108.192% |
| Neith Corporation | -48.85 Million TWD | 86.47% |
| Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 99.455% |
| Enimmune corporation | -243.47 Million TWD | 97.285% |
| TaiRx, Inc. | -214.69 Million TWD | 96.921% |
| CHO Pharma, Inc. | -268.99 Million TWD | 97.543% |
| EirGenix Inc. | -1.03 Billion TWD | 99.359% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 110.437% |
| Sunny Pharmtech Inc. | -72.09 Million TWD | 90.832% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | 92.918% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | 96.256% |
| Feng Chi Biotech Corp. | 24.16 Million TWD | 127.357% |
| Lukas Biomedical Inc. | -43.56 Million TWD | 84.826% |
| RBC Bioscience Corporation | 14.53 Million TWD | 145.464% |
| BiOptic Inc. | 44.05 Million TWD | 115.005% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | 88.352% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | 99.048% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | 89.455% |
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | 89.957% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 101.979% |
| Bio Preventive Medicine Corp. | -70.58 Million TWD | 90.635% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | 85.473% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 100.739% |
| Lin BioScience, Inc. | -1.09 Billion TWD | 99.397% |
| NaviFUS Corp. | -76.42 Million TWD | 91.351% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | 92.965% |
| Sinew Pharma Inc. | -186.25 Million TWD | 96.451% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | 90.236% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 104.136% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 98.24% |
| AP Biosciences Inc | -347.47 Million TWD | 98.098% |
| Medigen Biotechnology Corp. | -1.23 Billion TWD | 99.464% |
| 3D Global Biotech Inc. | -62.85 Million TWD | 89.483% |
| Pharmosa Biopharm Inc. | -2.82 Million TWD | -134.065% |
| Intech Biopharm Corporation | -304.39 Million TWD | 97.828% |
| Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 99.397% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | 84.065% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | 96.102% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 101.957% |
| TCI GENE Inc. | 10.04 Million TWD | 165.778% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | 94.806% |
| Senhwa Biosciences, Inc. | -311.11 Million TWD | 97.875% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | 96.885% |
| NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 292.487% |
| PharmaEngine, Inc. | 277.18 Million TWD | 102.385% |
| Savior Lifetec Corporation | -2.42 Million TWD | -173.14% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | 96.216% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 99.684% |
| Meribank Biotech Co., Ltd | -123.15 Million TWD | 94.633% |
| Acepodia, Inc. | -435.97 Million TWD | 98.484% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 98.645% |